Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Ischemic Stroke
SERIC-AIS
1 other identifier
interventional
912
1 country
1
Brief Summary
he purpose of this study is to determine the efficacy and safety of remote ischemic conditioning for acute ischemic stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2018
CompletedFirst Posted
Study publicly available on registry
September 13, 2018
CompletedStudy Start
First participant enrolled
June 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 20, 2026
October 2, 2024
February 1, 2024
1.3 years
August 27, 2018
October 1, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of patients with Modified Rankin Scale (mRS) Score 0-2
The primary outcome measure of efficacy is the modified Rankin Scale (mRS) dichotomized to define good functional outcome as mRS 0-2 at 90 days.score, dichotomized to define good functional outcome as mRS 0-2 at 90 days.
3 months
Secondary Outcomes (4)
NIHSS Score at end of 7th day of treatment
7 days
mRS Score at end of 7th day of treatment
7 days
Barthel Index at end of 7th day of treatment
7 days
Changes of hematological indicators
48h; 7days
Study Arms (2)
RIC+Standard medical treatment
ACTIVE COMPARATORRemote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflations of a blood pressure cuff to 200 mm Hg. RIC will be conducted twice daily for 7 days. Additionally,the patients will be treated with standard medical treatment according to Guidelines for diagnosis and treatment of acute ischemic stroke in China 2014
Sham RIC+Standard medical treatment
PLACEBO COMPARATORRemote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflations of a blood pressure cuff to 60 mm Hg. RIC will be conducted twice daily for 7 days. Additionally,the patients will be treated with standard medical treatment according to Guidelines for diagnosis and treatment of acute ischemic stroke in China 2014
Interventions
Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflations of a blood pressure cuff to 200 mm Hg. RIC will be conducted twice daily for 7 days.
Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflations of a blood pressure cuff to 60 mm Hg. RIC will be conducted twice daily for 7 days.
Eligibility Criteria
You may qualify if:
- )Age≥18 years, \< 80 years, regardless of sex;
- )Patients with clinically definite diagnosis of acute ischemic stroke and able to commence RIC treatment within 12 hours of stroke onset
- )Baseline NIHSS score\>5, and≤25 ;
- )GCS score ≥8;
- )Signed and dated informed consent is obtained
You may not qualify if:
- \) Patients with suspected posterior circulation infarction;
- \) Patients who undergo thrombolytic therapy or endovascular treatment;
- \) mRS≥2 score before the onset of the disease;
- \) Double upper limbs or lower limbs paralysis was found in this case;
- )Active bleeding of organs within 6 months of admission or current, including cerebral hemorrhage, subarachnoid hemorrhage, gastrointestinal hemorrhage, fundus hemorrhage and so on;
- \) Other intracranial lesions, such as cerebrovascular malformation cerebral venous diseases, tumor and other diseases involving the brain;
- \) Treated blood pressure ≤90mmHg/60mmHg or≥180mmHg/100mmHg;
- \) Severe organ dysfunction or failure;
- \) Persons suffering from severe hematological diseases or severe coagulation disorder dysfunction;
- \) Those who had a history of severe trauma or had major surgery within 6 months prior to admission;
- \) The patients who had the contraindication of remote ischemic conditioning treatment, such as severe soft tissue injury, fracture or vascular injury in the upper limb;Acute or subacute venous thrombosis, arterial occlusive disease, subclavian steal syndrome, etc;
- \) Pregnant or lactating women;
- \) Previous remote ischemic conditioning therapy or similar treatment;
- \) Patients with a life expectancy of less than 3 months or patients unable to complete the study for other reasons;
- \) Severe hepatic and renal dysfunction
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yi Yanglead
Study Sites (1)
First Hospital of Jilin University
Changchun, Jilin, 130000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical Trial and Research Center for Stroke
Study Record Dates
First Submitted
August 27, 2018
First Posted
September 13, 2018
Study Start
June 17, 2025
Primary Completion (Estimated)
September 20, 2026
Study Completion (Estimated)
September 20, 2026
Last Updated
October 2, 2024
Record last verified: 2024-02